PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 204 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $4,848,000 | +420.7% | 269,462 | +685.0% | 0.27% | +478.3% |
Q2 2019 | $931,000 | +14.9% | 34,328 | +47.0% | 0.05% | 0.0% |
Q1 2019 | $810,000 | -73.2% | 23,350 | -79.4% | 0.05% | -73.7% |
Q3 2018 | $3,019,000 | +80.1% | 113,350 | +155.5% | 0.18% | +65.1% |
Q2 2018 | $1,676,000 | +18522.2% | 44,372 | +23628.3% | 0.11% | +10500.0% |
Q4 2017 | $9,000 | -10.0% | 187 | -1.6% | 0.00% | 0.0% |
Q3 2017 | $10,000 | -28.6% | 190 | -23.1% | 0.00% | 0.0% |
Q2 2017 | $14,000 | -67.4% | 247 | -77.5% | 0.00% | -75.0% |
Q1 2017 | $43,000 | -65.6% | 1,100 | -75.0% | 0.00% | -77.8% |
Q4 2014 | $125,000 | – | 4,400 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |